MACAU DAILY TIMES 澳門每日時報

Top Menu

  • Our Team
  • Editorial Statute
    • Code of Ethics
    • Privacy Policy
    • Terms and Conditions
  • Archive
    • PDF Editions
  • Contacts
  • Extra Times
    • Drive In
    • Book It
    • tTunes
    • Features
    • World of Bacchus
    • Taste of Edesia

Main Menu

  • Home
  • Macau
    • Photo Shop
    • Advertorial
  • Interview
  • Greater Bay
  • Business
    • Corporate Bits
  • China
  • Asia
  • World
  • Sports
  • Opinion
    • Editorial
    • Our Desk
    • Business Views
    • China Daily
    • Multipolar World
    • The Conversation
    • World Views
  • Our Team
  • Editorial Statute
    • Code of Ethics
    • Privacy Policy
    • Terms and Conditions
  • Archive
    • PDF Editions
  • Contacts
  • Extra Times
    • Drive In
    • Book It
    • tTunes
    • Features
    • World of Bacchus
    • Taste of Edesia
logo
FOUNDER & PUBLISHER Kowie Geldenhuys
EDITOR-IN-CHIEF Paulo Coutinho
Macau,

MACAU DAILY TIMES 澳門每日時報

  • Home
  • Macau
    • Photo Shop
    • Advertorial
  • Interview
  • Greater Bay
  • Business
    • Corporate Bits
  • China
  • Asia
  • World
  • Sports
  • Opinion
    • Editorial
    • Our Desk
    • Business Views
    • China Daily
    • Multipolar World
    • The Conversation
    • World Views
  • China-Russia-US Heads of State Declaration toward Peace

  • APEC leaders back Shenzhen trade agenda as Xi meets Trump and Putin

  • Lawmakers call for stronger building management and measures to stabilize property market

  • Bill sets five grounds for dissolution of civil associations

  • Pansy Ho urges unified Greater Bay Area tourism strategy

  • Lawmakers get more speaking time under revised policy debate format

BusinessHeadlines
Home›Business›Big Pharma | AstraZeneca says Covid-19 vaccine shown to be ‘highly effective’

Big Pharma | AstraZeneca says Covid-19 vaccine shown to be ‘highly effective’

By -
Tuesday, November 24, 2020
86
0

AstraZeneca said yesterday that late-stage trials showed its coronavirus vaccine was up to 90% effective, giving public health officials hope they may soon have access to a vaccine that is cheaper and easier to distribute than some of its rivals.
The results are based on interim analysis of trials in the U.K. and Brazil of a vaccine developed by Oxford University and manufactured by AstraZeneca. No hospitalizations or severe cases of COVID-19 were reported in those receiving the vaccine.
AstraZeneca is the third major drug company to report late-stage results for a potential COVID-19 vaccine as the world anxiously waits for scientific breakthroughs that will bring an end to a pandemic that has wrought economic devastation and resulted in nearly 1.4 million confirmed deaths.
Pfizer and Moderna last week reported preliminary results from late-stage trials showing their vaccines were almost 95% effective. But, unlike its rivals, the AstraZeneca vaccine doesn’t have to be stored at ultra-cold temperatures, making it easier to distribute, especially in developing countries.
“I think these are really exciting results,” Dr. Andrew Pollard, chief investigator for the trial, said during a news conference. “Because the vaccine can be stored at fridge temperatures, it can be distributed around the world using the normal immunization distribution system. And so our goal […] to make sure that we have a vaccine that was accessible everywhere, I think we’ve actually managed to do that.”
The Oxford-AstraZeneca vaccine is also cheaper. AstraZeneca, which has pledged it won’t make a profit on the vaccine during the pandemic, has reached agreements with governments and international health organizations that put its price at about $2.50 a dose. Pfizer’s vaccine costs about $20 a dose, while Moderna’s is $15 to $25, based on agreements the companies have struck to supply their vaccines to the U.S. government.
All three vaccines must be approved by regulators before they can be widely distributed.
The results come as a second wave of COVID-19 hits many countries, once again shutting businesses, restricting social interaction and pummeling the world economy.
AstraZeneca said it will immediately apply for early approval of the vaccine where possible, and it will seek an emergency use listing from the World Health Organization, so it can make the vaccine available in low-income countries.
The AstraZeneca trial looked at two different dosing regimens. A half-dose of the vaccine followed by a full dose at least one month later was 90% effective. Another approach, giving patients two full doses one month apart, was 62% effective. The combined results showed an average efficacy rate of 70%.
The vaccine uses a weakened version of a common cold virus that is combined with genetic material for the characteristic spike protein of the virus that causes COVID-19. After vaccination, the spike protein primes the immune system to attack the virus if it later infects the body.
The vaccine can be transported under “normal refrigerated conditions” of 2 to 8 degrees Celsius, AstraZeneca said. By comparison, Pfizer plans to distribute its vaccine using specially designed “thermal shippers” that use dry ice to maintain temperatures of minus-70 degrees Celsius (minus-94 degrees Fahrenheit).
Peter Openshaw, professor of experimental medicine at Imperial College London, said the
The results reported yesterday come from trials in the U.K. and Brazil that involved 23,000 people. Late-stage trials are also underway in the U.S., Japan, Russia, South Africa, Kenya and Latin America, with further trials planned for other European and Asian countries.
AstraZeneca has been ramping up manufacturing capacity, so it can supply hundreds of millions of doses of the vaccine starting in January, Chief Executive Pascal Soriot said earlier this month. MDT/AP

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • Share on LinkedIn (Opens in new window) LinkedIn
  • Share on WhatsApp (Opens in new window) WhatsApp
  • Print (Opens in new window) Print

Like this:

Like Loading…

Related

Previous Article

Football | Records tumble as Liverpool beats ...

Next Article

This day in history | 1998 Queen’s ...

Related articles More from author

  • HeadlinesMacau

    Top court in favor of temporary residency cancelation of cross-border workers

    Friday, February 5, 2021
    By Renato Marques, MDT
  • Business

    Real Estate Matters | Clarifying costs for buyers – Part III

    Friday, April 21, 2017
    By -
  • Business

    They took his supercars, but dictator’s son still flaunts riches

    Friday, October 25, 2019
    By -
  • HeadlinesMacau

    10 ‘Eyes in the Sky’ cameras in Zone A commence operation

    Thursday, February 12, 2026
    By -
  • Business

    Las Vegas Sands to sell Pennsylvania casino for USD1.3 billion

    Friday, March 9, 2018
    By -
  • HeadlinesMacau

    IC’s new president | Cecilia Tse highlights administration transparency

    Wednesday, December 20, 2017
    By Julie Zhu, MDT

Leave a reply Cancel reply

You must be logged in to post a comment.

  • Macau

    Consumer Confidence Index increased at year-end

  • Asia-Pacific

    Australia | Sydney Opera House gets major upgrade to fix hated acoustics

  • BusinessCorporate Bits

    MUST students score accolade in 39th Mathematical Contest in Modeling

DAILY EDITION

Friday, November 20, 2026 – edition no. 5079
Friday, November 20, 2026 – edition no. 5079

Greater Bay

MDT MACAU GRAND PRIX SPECIAL

November 2026
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
« Oct    

Timeline

  • Friday, November 20, 2026

    China-Russia-US Heads of State Declaration toward Peace

  • Friday, November 20, 2026

    APEC leaders back Shenzhen trade agenda as Xi meets Trump and Putin

  • Friday, November 20, 2026

    Lawmakers call for stronger building management and measures to stabilize property market

  • Friday, November 20, 2026

    Bill sets five grounds for dissolution of civil associations

  • Friday, November 20, 2026

    Pansy Ho urges unified Greater Bay Area tourism strategy

  • Friday, November 20, 2026

    Lawmakers get more speaking time under revised policy debate format

  • Friday, November 20, 2026

    Over 85% of resident owners say Iao Hon redevelopment cannot wait

  • Friday, November 20, 2026

    Porsche leads surprise charge in opening GT World Cup sessions

  • Friday, November 20, 2026

    Rivera leads provisional FR World Cup qualifying after crash-hit session

  • Friday, November 20, 2026

    Red flags interrupt F4 practice as Killion tops timesheets

Extra Times

Drive InExtra Times

‘Madden’ biopic can’t find a playbook to stick with

Which play to run is a question that can bedevil any football coach, and it’s also what dooms David O. Russell’s fumbled biopic “Madden.” “Madden” may sport an all-star cast ...
  • Juksunchae: A Study in Precision and Contemporary Korean Cuisine

    By Irene Sam, MDT
    Friday, November 20, 2026
  • Reframing the “Hundreds of Flavors”: Chiang and Ho at Zi Yat Heen

    By -
    Friday, November 20, 2026
  • Three chefs. One horizon. Six Michelin stars

    By Irene Sam, MDT
    Friday, November 13, 2026
  • James Gray delivers a milestone crime drama in ‘Paper Tiger’

    By MDT/AP
    Friday, November 13, 2026
  • Recent

  • Popular

  • China-Russia-US Heads of State Declaration toward Peace

    By XINHUA
    Friday, November 20, 2026
  • APEC leaders back Shenzhen trade agenda as Xi meets Trump and Putin

    By Times Reporter
    Friday, November 20, 2026
  • Lawmakers call for stronger building management and measures to stabilize property market

    By Yuki Lei, MDT
    Friday, November 20, 2026
  • Bill sets five grounds for dissolution of civil associations

    By Yuki Lei, MDT
    Friday, November 20, 2026
  • Pansy Ho urges unified Greater Bay Area tourism strategy

    By Nadia Shaw, MDT
    Friday, November 20, 2026
  • Lawmakers get more speaking time under revised policy debate format

    By -
    Friday, November 20, 2026
  • Over 85% of resident owners say Iao Hon redevelopment cannot wait

    By Yuki Lei, MDT
    Friday, November 20, 2026
  • Canidrome may have its days numbered, decision in ‘one or two months’

    By Paulo Coutinho, MDT
    Thursday, May 26, 2016
  • Animal Welfare | Macau: Anima slams Canidrome management for avoiding debate

    By -
    Wednesday, May 4, 2016
  • Editorial | Canidoomed

    By Paulo Coutinho, MDT
    Wednesday, June 1, 2016
  • Animal Welfare | Canidrome presented with ultimatum: close or move

    By Daniel Beitler, MDT
    Friday, July 22, 2016
  • Australia regulator cracks down on alleged exportation of dogs to Macau

    By Paulo Coutinho, MDT
    Friday, June 10, 2016
  • Animal rights | Canidrome: Anima in fresh airline negotiations as Canidrome closure looks more likely

    By Daniel Beitler, MDT
    Friday, May 27, 2016
  • USE OF ENGLISH IN MACAU | A ‘de facto’ official language

    By Catarina Pinto
    Monday, July 6, 2015
  • Contact our Administrator
  • Contact our Editor-in-Chief
  • Contacts
  • Our Team
  • Privacy Policy
  • Terms and Conditions
  • Editorial Statute
  • Code of Ethics
COPYRIGHT © MACAU DAILY TIMES 2008-2026. ALL RIGHTS RESERVED
MACAU DAILY TIMES
  • Home
  • Macau
    • Photo Shop
    • Advertorial
  • Interview
  • Greater Bay
  • Business
    • Corporate Bits
  • China
  • Asia
  • World
  • Sports
  • Opinion
    • Editorial
    • Our Desk
    • Business Views
    • China Daily
    • Multipolar World
    • The Conversation
    • World Views
  • Our Team
  • Editorial Statute
    • Code of Ethics
    • Privacy Policy
    • Terms and Conditions
  • Archive
    • PDF Editions
  • Contacts
  • Extra Times
    • Drive In
    • Book It
    • tTunes
    • Features
    • World of Bacchus
    • Taste of Edesia
Loading Comments...

You must be logged in to post a comment.

%d